Recent HTAs and Canadian Guidelines
These reports are available without cost at the websites below:
Anti-TNF-α Drugs for Refractory Inflammatory Bowel
Disease: Clinical- and Cost-Effectiveness Analyses. CADTH, July 2009: http://www.cadth.ca/media/pdf/H0479_Anti_TNF_a_Drugs_for_Refractory_Inflammatory_Bowel_Disease_tr_e.pdf
Dabigatran or Rivaroxaban Versus Other Anticoagulants for
Thromboprophylaxis After Major Orthopedic Surgery: Systematic Review of
Comparative Clinical-Effectiveness and Safety. CADTH, May 2009: http://www.cadth.ca/media/pdf/M0006_Rivaroxaban_and_Dabigatran_L3_e.pdf
Cost-Effectiveness of Blood Glucose Test Strips in the
Management of Adult Patients with Diabetes Mellitus: http://www.cadth.ca/media/pdf/BGTS_SR_Report_of_Clinical_Outcomes.pdf and http://www.cadth.ca/media/pdf/BGTS_Consolidated_Economic_Report.pdf
Erythropoiesis-Stimulating Agents for Anemia of Cancer or of Chemotherapy: Systematic Review and Economic Evaluation. CADTH, April 2009: http://www.cadth.ca/media/pdf/H0468_Erythropoiesis-stimulating_agents_tr_e.pdf
Recombinant Activated Factor VII in Treatment of Hemorrhage
Unrelated to Hemophilia: A Systematic Review and Economic Evaluation. CADTH,
April 2009: http://www.cadth.ca/media/pdf/H0457A_Recombinant_Activated_Factor_VII_Hemorrhage_Hemophilia_tr_e.pdf
Dialectical Behaviour Therapy in Adolescents for Suicide
Prevention: Systematic Review of Clinical-Effectiveness. CADTH, April 2009: http://www.cadth.ca/media/pdf/M0005_Dialectical_Behaviour_Therapy_Adolescents_Suicide_Prevention%20_L3_e.pdf
Drugs for Pulmonary Arterial Hypertension: A Systematic Review of the Clinical-Effectiveness of Combination Therapy. CADTH, April 2009: http://www.cadth.ca/media/pdf/M0004_Drugs_for_Pulmonary_Arterial_Hypertension_tr_e.pdf
Octaplas Compared With Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis. CADTH, April 2009: http://www.cadth.ca/media/pdf/I4002_Octaplas%20versus%20FFP_L4_e_April%202009.pdf
Intravenous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy: Clinial and Cost-Effectiveness Analysis. CADTH, March 2009: http://www.cadth.ca/media/pdf/298_Intravenous_Immunoglobulin_CIPD_tr_e.pdf
Portable Ultrasonography in Small Emergency Departments: A Systematic Review of the Guidelines and Clinical-Effectiveness. CADTH, March 2009: http://www.cadth.ca/media/pdf/M0003_Portable_Ultrasound_in_Small_Emergency_Departments_L3_e.pdf
HTAs From Other Organizations
Systematic Review of the Effects of Home Telemonitoring in the Context of Diabetes, Pulmonary Diseases, and Cardiovascular Diseases. Aetmis, 2009: http://www.aetmis.gouv.qc.ca/site/phpwcms_filestorage/3b71f5915e1885970d1cf484d13e347e.pdf
Telemedicine and Radiation Oncology: State of the Evidence: Aetmis, 2009. Assistive Reproductive Technologies: A Literature Review and Database Analysis. Institute of Health Economics, 2009: http://www.ihe.ca/documents/Assistive_Reproductive_Technologies.pdf
Determinants and Prevention of Low Birth Weight: A Synopsis of the Evidence. Institute of Health Economics, 2009: http://www.ihe.ca/documents/IHE%20Report%20LowBirthWeight%20final.pdf
Effectiveness of Organizational Interventions for the Prevention of Workplace Stress. Institute of Health Economics, 2009: http://www.ihe.ca/documents/Interventions_for_prevention_of_workplace_stress.pdf
The Development of a PET/CT Program in Newfoundland and Labrador. Newfoundland and Labrador Centre for Applied Health Research, CHRSP, 2009: http://www.nlcahr.mun.ca/research/chrsp/EIC_PetCT_full_report.pdf
Effective Non-Clinical Interventions to Prevent and Treat Childhood Overweight and Obesity in Newfoundland and Labrador. Newfoundland and Labrador Centre for Applied Health Research, CHRSP, 2009: http://www.nlcahr.mun.ca/research/chrsp/EIC_Childhood_Obesity_Full_Report.pdf
Clopidogrel for the Treatment of Adult Patients Following Acute Coronary Syndrome. Alberta Health Technology Assessment Coalition Therapeutics Initiative, 2009: http://ti.ubc.ca/node/446
Estradiol/Levonorgestrel (Seasonale) for Prevention of Pregnancy. Alberta Health Technology Assessment Coalition Therapeutics Initiative, 2009: http://ti.ubc.ca/node/374
Imiquimod Cream for the Treatment of Adult Patients With Actinic Keratosis. Alberta Health Technology Assessment Coalition Therapeutics Initiative, 2009: http://www.ti.ubc.ca/node/419
Calcipotriol/Betamethasone (Dovobet) Ointment for the Treatment of Adult Patients With Psoriasis Vulgaris. Alberta Health Technology Assessment Coalition Therapeutics Initiative, 2009: http://www.ti.ubc.ca/node/417
Pressure Ulcer Prevention: An Evidence-Based Analysis. Ontario Medical Advisory Secretariat, 2009: http://www.health.gov.on.ca/english/providers/program/mas/tech/reviews/pdf/rev_pup_20090401.pdf
Intrastromal Corneal Ring Implants for Corneal Thinning Disorders. Ontario Medical Advisory Secretariat, 2009: http://www.health.gov.on.ca/english/providers/program/mas/tech/reviews/pdf/rev_intacs_20090401.pdf
New Canadian Practice Guidelines
Canadian Cardiovascular Society consensus conference update on cardiac transplantation 2008: Executive Summary. Can J Cardiol 2009:25(4): http://www.ccs.ca/download/consensus_conference/consensus_conference_archives/2009_CardiacTransplantationUpdate.pdf
The 2009 Canadian Hypertension Education Program Recommendations: An Annual Update. Canadian Hypertension Education Program, 2009: http://hypertension.ca/chep/wp-content/uploads/2009/05/chep-recommendations-spiral-bookleten.pdf
Guideline for using point of care INR monitoring of Warfarin therapy. Thrombosis Interest Group of Canada, 2009: http://www.tigc.org/pdf/PointOfCareWarfarinTherapy.pdf
The Use of Inhibitors of Angiogenesis in Patients With Inoperable Locally Advanced or Metastatic Renal Cell Cancer: Guideline Recommendations. Cancer Care Ontario, 2009: http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=43557
The ‘what, when, where, who and how?’ of cardiac computed tomography in 2009: Guidelines for the clinician. Can J Cardiol 2009:25(3).
Reporting adverse reactions to antiviral drugs during an influenza pandemic ― guidelines for health professionals and consumers. PHAC, 2009: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/medeff/2009_ar-ei_anti_guide-ldir-eng.pdf
H1N1 flu virus Interim Guidelines, June 15th, 2009. PHAC, 2009: http://www.phac-aspc.gc.ca/ols-bsl/banhsl-abnhgp-eng.php
Use of antivirals to treat H1N1 flu virus (Human Swine Flu). PHAC, 2009: http://www.phac-aspc.gc.ca/alert-alerte/swine-porcine/antiviral-antiviraux05-01-eng.php
Management guidelines for pregnant women and neonates born to women with suspected or confirmed H1N1 influenza A (human swine flu) ― Interim Guidelines (draft). British Columbia Perinatal Health Program, 2009: http://bcphp.ca//sites/bcrcp/files/spotlight/guideline_h1n1_interim_draft.pdf
Content of a complete routine second trimester obstetrical ultrasound examination and report. SOGC, 2009: http://www.sogc.org/guidelines/documents/gui223CPG0903.pdf
Gastroscopy Following a Positive Fecal Occult Blood Test and Negative Colonoscopy: Guideline Recommendations. Cancer Care Ontario, 2009: http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=43562
Gastroesophageal Reflux Disease ― Clinical Approach in Adults. BC Guidelines and Protocols Advisory Committee, 2009: http://www.bcguidelines.ca/gpac/pdf/gastro.pdf
Menopause and Osteoporosis Update 2009. SOGC, 2009: http://www.sogc.org/guidelines/documents/Menopause_JOGC-Jan_09.pdf
Management of Meconium at Birth. SOGC, 2009: http://www.sogc.org/guidelines/documents/gui224TU0904.pdf
Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS), SOGC, 2009: http://www.sogc.org/guidelines/documents/gui225CPG0904.pdf
Guideline for the Evidence-Informed Primary Care Management of Low Back Pain. Towards Optimized Practice, Alberta, 2009: http://www.topalbertadoctors.org/PDF/complete%20set/Low%20Back%20Pain/backpain_guideline.pdf
Vision screening in infants, children and youth. Canadian Paediatric Society, 2009: http://www.cps.ca/english/statements/CP/cp09-02.htm